FLPIM
GSK icon

F.L. Putnam Investment Management’s GSK GSK Stock Holding History

F.L. Putnam Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Sell
8,324
-477
-5% -$25.2K 0.01% 490
2026
Q1 		$486K Buy
8,801
+1,464
+20% +$79.3K 0.01% 424
2025
Q4 		$360K Buy
7,337
+748
+11% +$34.9K 0.01% 486
2025
Q3 		$284K Sell
6,589
-191
-3% -$7.46K ﹤0.01% 507
2025
Q2 		$260K Buy
6,780
+768
+13% +$29.3K ﹤0.01% 516
2025
Q1 		$233K Buy
6,012
+98
+2% +$3.59K ﹤0.01% 527
2024
Q4 		$200K Sell
5,914
-6,524
-52% -$235K ﹤0.01% 550
2024
Q3 		$482K Buy
12,438
+401
+3% +$16.4K 0.01% 435
2024
Q2 		$463K Buy
12,037
+3,401
+39% +$143K 0.01% 428
2024
Q1 		$370K Buy
8,636
+3,234
+60% +$133K 0.01% 381
2023
Q4 		$200K Buy
+5,402
New +$194K ﹤0.01% 464
2020
Q3 		– Sell
-5,516
Closed -$281K – 305
2020
Q2 		$281K Sell
5,516
-21
-0.4% -$1.08K 0.02% 260
2020
Q1 		$262K Buy
5,537
+1,290
+30% +$68.8K 0.02% 248
2019
Q4 		$249K Buy
4,247
+2
+0% +$111 0.02% 281
2019
Q3 		$226K Buy
4,245
+524
+14% +$27K 0.02% 268
2019
Q2 		$186K Buy
+3,721
New +$187K 0.02% 223

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

F.L. Putnam Investment Management's GSK Position: Q2 2026 in Review

F.L. Putnam Investment Management reduced its GSK (GSK) stake by 5.4% in Q2 2026, selling an estimated $25.2K and leaving 8,324 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #490.

F.L. Putnam Investment Management first reported a position in GSK in Q2 2019 and has held it in 16 quarters since. The position peaked at $486K in Q1 2026. 684 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • F.L. Putnam Investment Management held 8,324 shares of GSK worth $436K as of Q2 2026.
  • F.L. Putnam Investment Management sold 477 GSK shares in Q2 2026, an estimated $25.2K.
  • GSK made up 0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #490 holding.
  • F.L. Putnam Investment Management first reported a position in GSK in Q2 2019 and has held it in 16 quarters since.
  • F.L. Putnam Investment Management's GSK position peaked at $486K in Q1 2026.
  • 684 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.